Cargando…
Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10
A disintegrin and metaproteinase 10 is an important target for multiple therapeutic areas, however, despite drug discovery efforts by both industry and academia no compounds have reached the clinic so far. The lack of enzyme and substrate selectivity of developmental drugs is believed to be a main o...
Autor principal: | Minond, Dmitriy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218085/ https://www.ncbi.nlm.nih.gov/pubmed/32435655 http://dx.doi.org/10.3389/fmolb.2020.00075 |
Ejemplares similares
-
ADAMTS-12: Functions and Challenges for a Complex Metalloprotease
por: Mohamedi, Yamina, et al.
Publicado: (2021) -
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate
por: Madoux, Franck, et al.
Publicado: (2016) -
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis
por: Cinetto, Francesco, et al.
Publicado: (2021) -
Structure-Function Relationship of the Disintegrin Family: Sequence Signature and Integrin Interaction
por: Vasconcelos, Ariana A., et al.
Publicado: (2021) -
Effect of type 2 diabetes on A disintegrin and metalloprotease 10
por: Lam, Sum, et al.
Publicado: (2022)